Abstract
Drug delivery has experienced an outstanding advance in the last few decades. Two key elements have contributed in a large extent to such a progress: the better knowledge of the physio/pathological environments through which the drugs have to pass through to reach their targets, and the development of novel excipients that actively participate in the accomplishment of the aimed delivery. In this context polymers occupy an outstanding position due to the versatility of the synthesis routes and the possibility of tuning their features and performances to fulfill the needs of every particular application. Polymers can finely regulate the site and the rate at which the drug is released from the formulation, improve drug solubility, contribute to the stability in the physiological environment, and help the drug to overcome cellular barriers, facilitating the contact with the therapeutic diana. This Chapter reviews the role of polymers on the evolution of drug delivery systems and the current performances they are expected to play in improving the efficiency and safety of the treatments with both old and novel active pharmaceutical ingredients (APIs). An analysis of how polymers themselves are contributing to optimize classical methods of preparing drugs dosage forms and to envision advanced drug nanocarriers is also included. Whenever possible, the information was organized trying to offer structure-property-functionality relationships, with examples of commercially available materials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ABC:
-
ATP binding cassette
- API:
-
Active pharmaceutical ingredient
- ATP:
-
Adenosine triphosphate
- BCRP:
-
Breast cancer resistant protein
- CAP:
-
Cellulose acetate phthalate
- EMA:
-
European Medicines Agency
- FDA:
-
US Food and Drug Administration
- HLB:
-
Hydrophilic-lipophilic balance
- HPC:
-
Hydroxypropylcellulose
- HPMC:
-
Hydroxypropyl methylcellulose
- MCC:
-
Microcrystalline cellulose
- MRP:
-
Multidrug resistant proteins
- P-gp:
-
P-glycoprotein
- PAA:
-
Poly(acrylic acid)
- PAMAM:
-
Polyamidoamine
- PCL:
-
Poly-ε-caprolactone
- PEI:
-
Polyethyleneimine
- PEO:
-
Poly(ethylene oxide)
- PGA:
-
Poly(glycolic acid)
- PLA:
-
Poly(lactic acid)
- PLGA:
-
Polylactic-co-glycolic acid
- PPO:
-
Poly(propylene oxide)
- PVP:
-
Polyvinylpyrrolidone
- ROS:
-
Reactive oxygen species
- SMCC:
-
Silicified microcrystalline cellulose
- Tg :
-
Glass transition temperature
References
Allen, L.V., Popovich, N.G., Ansel, H.C.: Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. Lippincott Williams & Wilkins, Baltimore (2011). Chapter 1
Krówczynski, L.: The development of pharmaceutical technology (chronological tabulated facts). Pharmazie 40, 346 (1985)
Alvarez-Lorenzo, C., Concheiro, A.: From drug dosage forms to intelligent drug-delivery systems: a change of paradigm. In: Alvarez-Lorenzo, C., Concheiro, A. (eds.) Smart materials for drug delivery, vol. 1, p. 1. Royal Society of Chemistry Publishing, Cambridge (2013)
Dokoumetzidis, A., Macheras, P.: A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int. J. Pharm. 321, 1 (2006)
Hoffman, A.S.: The origins and evolution of “controlled” drug delivery systems. J. Control. Release 18, 153 (2008)
Alvarez-Lorenzo, C., Concheiro, A.: Smart drug delivery systems: from fundamentals to the clinic. Chem. Comm. 50, 7743 (2014)
Hon, D.N.S.: Cellulose and its derivatives: structures, reactions and medical uses. In: Dumitriu, S. (ed.) Polysaccharides in Medicinal Applications, p. 87. Marcel Dekker, New York (1996)
Rowe, R.C., Sheskey, P.J., Cook, W.G., Fenton, M.E.: Handbook of Pharmaceutical Excipients. Pharmaceutical Press, London (2012)
Zhang, Y., Law, Y., Xhakrabarti, S.: Physical properties and compact analysis of commonly used direct compression binders. AAPS PharmSciTech 4, 489 (2003)
Alvarez-Lorenzo, C., Gomez-Amoza, J.L., Martinez-Pachecho, R., Souto, C., Concheiro, A.: Evaluation of low-substituted hydroxypropylcellulose as filler-binders for direct compression. Int. J. Pharm. 197, 107 (2000)
Chen, L., Li, X., Li, L., Guo, S.: Acetylated starch-based biodegradable materials with potential biomedical applications as drug delivery systems. Curr. Appl. Phys. 7(s1), 90 (2007)
Rashid, I., Al Omari, M.M.H., Badwan, A.A.: From native to multifunctional starch-based excipients designed for direct compression formulation. Starch 65, 552 (2013)
Lee, Y.K., Mooney, D.J.: Alginate: properties and biomedical applications. Prog. Polym. Sci. 37, 106 (2012)
Pawar, S.N., Edgar, K.J.: Alginate derivatization: a review of chemistry, properties and applications. Biomaterials 33, 3279 (2012)
Tonnesen, H.H., Karlsen, J.: Alginate in drug delivery systems. Drug. Dev. Ind. Pharm. 28, 621 (2002)
Coviello, T., Matricardi, P., Marianecci, C., Alhaique, F.: Polysaccharide hydrogels for modified release formulations. J. Control. Rel. 119, 5 (2007)
Freile-Pelegrín, Y., Murano, E.: Agars from three species of Gracilaria (Rhodophyta) from Yucatán Peninsula. Bioresour. Technol. 96, 295 (2005)
Bühler, V.: Kollidon®, polyvinylpyrrolidone excipients for the pharmaceutical industry, 9th edn. BASF, Ludwigshafen (2008)
Lubrizol.: Pharmaceutical Bulletin 1. http://www.lubrizol.com/Life-Science/Documents/Pharmaceutical/Bulletins/Bulletin-01—Polymers-for-Pharmaceutical-Applications.pdf (2011). Accessed on June 2014
Danhier, F., Ansorena, E., Silva, J.M., Coco, R., Le Breton, A., Preat, V.: PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release. 161, 505 (2012)
Tahara, K., Sakai, T., Yamamoto, H., Takeuchi, H., Kawashima, Y.: Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. Int. J. Pharm. 354, 210 (2008)
Makadia, H.K., Siegel, S.J.: Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3, 1377 (2011)
Woodruff, M.A., Hutmacher, D.W.: The return of a forgotten polymer—Polycaprolactone in the 21st century. Progr. Polym. Sci. 35, 1217 (2010)
Joshi, S., Petereit, H.U.: Film coatings for taste masking and moisture protection. Int. J. Pharm. 457, 395 (2013)
Maroni, A., Zema, L., Loreti, G., Palugan, L., Gazzaniga, A.: Film coatings for oral pulsatile release. Int. J. Pharm. 457, 362 (2013)
Farag, Y., Leopold, C.S.: Development of shellac-coated sustained release pellet formulations. Eur. J. Pharm. Sci. 42, 400 (2011)
Pearnchob, N., Siepmann, J., Bodmeier, R.: Pharmaceutical application of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets. Drug. Dev. Ind. Pharm. 29, 925 (2003)
Felton, L.A., Porter, S.C.: An update on pharmaceutical film coating for drug delivery. Expert. Opin. Drug Del. 10, 421 (2013)
Wong, T.W., Colombo, G., Sonvico, F.: Pectin matrix as oral drug delivery vehicle for colon cancer treatment. AAPS. Pharm. Sci. Tech. 12, 201 (2011)
Siew, L.F., Basit, A.W., Newton, J.M.: The properties of amylose–ethylcellulose films cast from organic-based solvents as potential coatings for colonic drug delivery. Eur. J. Pharm. Sci. 11, 133 (2000)
Vervoort, L., Kinget, R.: In vitro degradation by colonic bacteria of inulin HP incorporated in Eudragit films. Int. J. Pharm. 129, 185 (1996)
Brøndsted, H., Andersen, C., Hovgaard, L.: Crosslinked dextran—a new capsule material for colon targeting of drugs. J. Control. Release. 53, 7 (1998)
Nollenberger, K., Albers, J.: Poly(meth)acrylate-based coatings. Int. J. Pharm. 457, 461 (2013)
Bühler, V.: Kollicoat grades. BASF, Ludwigshafen (2007)
Fahr, A., Liu, X.: Drug delivery strategies for poorly water-soluble drugs. Expert. Opin. Drug. Del. 4, 403 (2007)
Lu, Y., Park, K.: Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int. J. Pharm. 453, 198 (2013)
Chiappetta, D.A., Sosnik, A.: Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm. Biopharm. 66, 303 (2007)
Rangel-Yagui, C.O., Pessoa, A., Tavares, L.C.: Micellar solubilization of drugs. J. Pharm. Pharm. Sci. 8, 147 (2005)
Kwon, G.S.: Polymeric micelles for delivery of poorly water-soluble compounds. Crit. Rev. Ther. Drug Carrier Syst. 20, 357 (2003)
Kabanov, K.V., Batrakova, E.V., Alakhov, V.Y.: Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release. 82, 189 (2002)
Alvarez-Lorenzo, C., Rey-Rico, A., Sosnik, A., Taboada, P., Concheiro, A.: Poloxamine-based nanomaterials for drug delivery. Front. Biosci. (Elite edition) 2, 424 (2010)
Dumortier, G., Groissord, J.L., Agnely, F., Chaumeil, J.C.: A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 211, 2709 (2006)
Linn, M., Collnot, E.M., Djuric, D., Hempel, K., Fabian, E., Kolter, K., Lehr, C.M.: Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur. J. Pharm. Sci. 45, 336 (2012)
Cespi, M., Casettari, L., Palmieri, G.F., Perinelli, D.R., Bonacucina, G.: Rheological characterization of polyvinyl caprolactam–polyvinyl acetate–polyethylene glycol graft copolymer (Soluplus®) water dispersions. Colloid. Polym. Sci. 292, 235 (2014)
Shamma, R.N., Basha, M.: Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: formulation design and effect of method of preparation. Powder Technol. 237, 406 (2013)
Vo, C.L.N., Park, C., Lee, B.J.: Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur. J. Pharm. Biopharm. 85, 799 (2013)
Serajuddin, A.T.M.: Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88, 1058 (1999)
Kumar, S., Gupta, S.K.: Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs. Recent. Pat. Drug. Deliv. Formul. 7, 111 (2013)
Wilson, M., Williams, M.A., Jones, D.S., Andrews, G.P.: Hot-melt extrusion technology and pharmaceutical application. Ther. Deliv. 3, 787 (2012)
Leuner, C., Dressman, J.: Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50, 47 (2000)
Janssens, S., van den Mooter, G.: Review: physical chemistry of solid dispersions. J. Pharm. Pharmacol. 61, 1571 (2009)
Hardung, H., Djuric, D., Shaukat, A.: Combining HME & solubilization: Soluplus®-the solid solution. Drug. Deliv. Tech. 10, 3 (2010)
Ravina-Eirin, E., Gomez-Amoza, L., Martinez-Pacheco, R.: Utility of the hyperbranched polymer hybrane S1200 for production of instant-release particles by hot melt extrusion. Drug. Dev. Ind. Pharm. 39, 1107 (2013)
Deli, M.A.: Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim. Biophys. Acta 1788, 892 (2009)
Illum, L.: Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15, 1326 (1998)
Smith, J., Wood, E., Dornish, M.: Effect of chitosan on epithelial cell tight junctions. Pharm. Res. 21, 43 (2004)
Di Colo, G., Zambito, Y., Zaino, C.: Polymeric enhancers of mucosal epithelia permeability: synthesis, transepitheliar penetration-enhancing properties, mechanism of action, safety issues. J. Pharm. Sci. 97, 1652 (2008)
Thanou, M., Nihot, M.T., Jansen, M., Verhoef, J.C., Junginger, H.E.: Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo. J. Pharm. Sci. 90, 38 (2001)
Sandri, G., Rossi, S., Bonferoni, M.C., Ferrari, F., Zambito, Y., Di Colo, G., Caramella, C.: Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule. Int. J. Pharm. 297, 146 (2005)
Mourya, V., Inamdar, B.: Trimethyl chitosan and its applications in drug delivery. J. Mater. Sci. Mater. Med. 20, 1057 (2009)
Andrews, G.P., Laverty, T.P., Jones, D.S.: Mucoadhesive polymeric platforms for controlled drug delivery. Eur. J. Pharm. Biopharm. 71, 505 (2009)
Clausen, A.E., Bernkop-Schnurch, A.: In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J. Pharm. Sciences. 89, 1253 (2000)
Iqbal, J., Shahnaz, G., Perera, G., Hintzen, F., Sarti, F., Berkop-Schnurch, A.: Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide. Eur. J. Pharm. Biopharm. 80, 85 (2012)
Bernkop-Schnurch, A., Kast, C.E., Richter, M.F.: Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J. Control. Release. 28, 277 (2001)
Trapani, A., Palazzo, C., Contino, M., Perrone, M.G., Cioffi, N., Ditaranto, N., Colabufo, N.A., Conese, M., Trapani, G., Puglisi, G.: Mucoadhesive properties and interaction with P-glycoprotein (P-gp) of thiolated-chitosans and -glycol chitosans and corresponding parent polymers: a comparative study. Biomacromol 15, 882 (2014)
Bernkop-Schnürch, A., Grabovac, V.: Polymeric efflux pump inhibitors in oral drug delivery. Am. J. Drug. Del. 4, 263 (2006)
Eckford, P.D.W., Sharom, F.J.: ABC efflux pump-based resistance to chemotherapy drugs. Chem. Rev. 109, 2989 (2009)
Leveque, D., Jehl, F.: P-glycoprotein and pharmacokinetics. Anticancer. Res. 15, 331 (1995)
Yokoyama, M.: Polymeric micelles as a new drug carrier system and their required considerations for clinical trials. Expert. Opin. Drug. Del. 7, 145 (2010)
Loo, T.W., Clarke, D.M.: Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux. J. Membrane. Biol. 206, 173 (2005)
Varma, M.V., Perumal, O.P., Panchagnula, R.: Functional role of P-glycoprotein in limiting peroral drug absorption:optimizing drug delivery. Curr. Opin. Chem. Biol. 10, 367 (2006)
Werle, M.: Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm. Res. 25, 500 (2008)
Kabanov, A.V., Batrakova, E.V., Alakhov, V.Y.: Pluronic block copolymers for overcoming drug resistance in cancer. Adv. Drug Deliv. Rev. 54, 759 (2002)
D’Emanuele, A., Jevprasesphant, R., Penny, J., Attwood, D.: The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J. Control. Release. 95, 447 (2004)
Föger, F., Hoyer, H., Kafedjiiski, K., Thaurer, M., Bernkop-Schnürch, A.: In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein. Biomaterials 27, 5855 (2006)
Kabanov, A.V., Alkhov, VYu.: Pluronic® block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Critical. Rev. Therap. Drug. Carrier. Syst. 19, 1 (2002)
Cambón, A., Rey-Rico, A., Barbosa, S., Soltero, J.F.A., Yeates, S.G., Brea, J., Loza, M.I., Alvarez-Lorenzo, C., Concheiro, A., Taboada, P., Mosquera, V.: Poly(styrene oxide)-poly(ethylene oxide) block copolymers: From “classical” chemotherapeutic nanocarriers to active cell-response inducers. J. Control. Release. 167, 68 (2013)
Alakhova, D.Y., Rapoport, N.Y., Batrakova, E.V., Timoshin, A.A., Li, S., Nicholls, D., Alakhov, V.Y., Kabanov, A.V.: Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J. Control. Release. 142, 89 (2010)
Kan, P.L., Schätzlein, A.G., Uchegbu, I.F.: Polymers used for the delivery of genes in gene therapy. In: Uchegbu, I.F., Schätzlein, A.G. (eds.) Polymers in Drug Delivery, p. 183. CRC/Taylor and Francis, Boca Raton (2006)
Yue, Y., Wu, C.: Progress and perspectives in developing polymeric vectors for in vitro gene delivery. Biomater. Sci. 1, 152 (2013)
Acknowledgments
This work was supported by MICINN (SAF2011-22771), Xunta de Galicia (CN 2012/045), and FEDER. L. Diaz-Gomez acknowledges MICINN for a FPI fellowship (BES-2012-051889).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Díaz-Gómez, L., Concheiro, A., Alvarez-Lorenzo, C. (2015). Polymers in Drug Delivery: Fundamentals. In: Puoci, F. (eds) Advanced Polymers in Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-12478-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-12478-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12477-3
Online ISBN: 978-3-319-12478-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)